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Aim: Tumors of unknown primary (TUP)accounts for 3-5% of all new cancer diagnosis and is the 
seventh most commonmalignancy. TUP is defined as a biopsy proven malignancy whose 
anatomicalorigin remains unidentified after passing through extensive diagnosticevaluation. Overall, 
the PET detection rate of the primary lesion is about 39%.The purpose of our study was to evaluate 
the clinical value of 18F-FDGPET in patients with the clinical information of TUP, who performed a 
scan inour institution during a five year period. Materials and Methods: We retrospectively 
reviewed thecharts of 80 patients (33 women; 47 men, mean age 60.3±12.9 years) referred fora 18F-
FDG PET/CT scan because of metastases from unknown primarysites (13 patients with metastatic 
cervical adenopathy; 67 patients withextracervical metastases), between January 2005 and January 
2010. Only patientswith histologically or cytologically proven malignancy and who underwent 
anextensive diagnostic work up previous to the PET/CT scan were included. PETimages were 
obtained 45 to 60 minutes after 18F-FDG injection andlow dose CT images were used for attenuation 
correction and anatomic mapping.Correlative final histopathologic/cytologically findings and clinical 
follow-up(for a mean period of 24.9 months) were used to assess the results of 18F-FDGPET/CT. 
Results: Ofthe 80 patients evaluated, 48 (60%) showed abnormal tracer accumulations. In 38
(47.5%) of those 80 patients 18F-FDG PET/CT was true positive, identifying, morefrequently, the 
primary tumor in the lung and oropharynx. In 10 (12.5%) of the80 patients 18F-FDG PET/CT was 
false positive and in 14 (17.5%) didnot reveal lesions suspected to be the primary; however, primary 
tumors werefound in these 14 patients during clinical follow up (false negatives). In 18(22.5%) of 
the 80 patients 18F-FDG PET/CT did not reveal lesionssuspected to be the primary; however, 
primary tumors were not found in thesepatients at clinical follow up. Conclusion: In our experience 
18F-FDG PET/CThad a true positive result of 47.5% in the detection of the unknown primarytumor 
in patients referred with a TUP diagnosis. We believe that our resultsfavor the use of 18F-FDG 
PET/CT in an earlier stage in the TUPdiagnostic workup but further clinical research and cost-
benefit analysis isstill necessary. 
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